Luca Benatti - Oct 23, 2023 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Luca Benatti
Stock symbol
QNCX
Transactions as of
Oct 23, 2023
Transactions value $
$0
Form type
3
Date filed
10/24/2023, 07:43 PM
Previous filing
May 25, 2023
Next filing
Nov 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNCX Common Stock 80.3K Oct 23, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.